Avi Lasarow is a serial entrepreneur with a track record of identifying inflection points early, building businesses before categories mature, and scaling innovation into real world adoption. His work spans consumer genomics, diagnostics and regulated health technology, and now infrastructure-led financial inclusion across Africa.
From the earliest days of consumer genetic testing to national scale programmes delivered under pressure, Avi’s entrepreneurial journey has consistently been defined by speed of execution, commercial discipline and measurable impact.
Long before genetic testing became mainstream, Avi founded and built early ventures in the field, including DNA Bioscience in the early 2000s. At the time, personalised health and consumer genomics were still in their infancy, with limited public understanding and no established commercial playbook.
This early conviction became a hallmark of Avi’s career: recognising where science and technology were heading, then building platforms that made those advances accessible, actionable and scalable.
Avi’s entrepreneurial path has repeatedly involved building at the edge of new consumer technology categories. This includes his involvement in health innovation initiatives such as Mole Detective, a mobile diagnostic application that reflected the early shift towards consumer-led digital health tools and smartphone enabled preventative health awareness.
Avi’s work has consistently focused on translating innovation into adoption: building businesses that take science, data and technology and convert them into products people can use, trust and benefit from.
Avi later founded and scaled DNAfit, which became one of the best known consumer genomics and personalised wellness businesses internationally. DNAfit helped pioneer the category of DNA led health optimisation and performance insight, building credibility with both consumers and institutional partners, and ultimately becoming part of the wider global diagnostics movement.
Avi then served as CEO EMEA of Prenetics, one of the world’s leading diagnostics and genetic testing companies, during its $1bn plus Nasdaq IPO in May 2022. Under Avi’s leadership, Prenetics’ UK based EMEA division contributed more than half of Prenetics’ global $275m revenue in 2021, demonstrating his ability to build commercial engines inside high growth technology businesses.
A defining feature of Avi’s entrepreneurship is the ability to mobilise teams, partners and infrastructure quickly, delivering in high trust environments where compliance, governance and discretion matter as much as innovation.
During the COVID era, Avi played a leadership role in delivering large scale diagnostics programmes that supported national recovery and business continuity. Under his leadership, Prenetics secured the UK Premier League’s COVID testing programme for Project Restart, supporting the safe return of elite football at the height of the pandemic. This was the first contract of its kind in history with one of the most recognised sporting leagues on the planet. Closing the agreement required direct engagement with key stakeholders across the league, including club captains, medical doctors and senior management, aligning multiple interests around a solution trusted at the highest level.
While much of Avi’s earlier career centred on health innovation, his entrepreneurial focus has broadened meaningfully. The next chapter is not only about consumer products or diagnostics, but about building platforms that improve the resilience of systems and expand access at population level.
Avi has long believed that the most important innovations are those that reach everyone, not only those who can afford premium solutions. This principle now shapes his focus on infrastructure-led inclusion, where technology can unlock opportunity at national scale.
Today, Avi’s primary entrepreneurial focus is Finergi, an infrastructure fintech business built on proprietary IP designed to accelerate financial inclusion across emerging markets, with a clear emphasis on Africa.
Finergi turns utility meter behaviour into credit scores, converting real time consumption and payment data into trusted affordability and risk signals. This creates a powerful bridge between essential services and access to finance, enabling households to remain connected while giving utilities modern tools to improve collections, reduce losses and strengthen customer engagement.
At its core, Finergi is designed to unlock fairer financial pathways for millions of people by using real world behaviour as proof of affordability and reliability.
Avi is deeply passionate about Africa and its immense potential. Finergi reflects that commitment. It is not simply a business, but a long term platform intended to strengthen infrastructure resilience, support national development goals and unlock inclusion at scale across the continent.
Through Finergi and its partners, Avi is working with utilities, regulators and national stakeholders to support scalable rollouts, delivering practical innovation that can be implemented nationally.
Avi’s entrepreneurial approach is shaped by a small number of principles:
Whether in early genomics, consumer health technology, diagnostics infrastructure or financial inclusion, Avi’s mission remains consistent: to build ventures that materially improve lives through innovation, execution and inclusion at scale.